The vaccine maker is reportedly waiting for a green light from U.S. regulators before shipping out the doses.
Between 30 to 50 million doses of Johnson & Johnson's Covid-19 vaccine are sitting unused in a Baltimore plant that was previously forced to halt its operations due to contamination,A box of Johnson & Johnson's Covid-19 vaccine doses are pictured at Grubb's Pharmacy on CapitolEmergent BioSolutions, the contract manufacturer who produced the doses, is still waiting for a green light from the Food and Drug Administration to ship the doses, Reuters reported, citing two unnamed...
The report notes that pinning down the exact number of doses is difficult since the plant manufactures the raw vaccine itself and does not fill the product into vials. After being forced to halt its operations in April, Emergent has reportedly resumed making new vaccines, but the FDA is yet to inspect and authorize the plant.24.7 million. That’s the total number of Johnson & Johnson Covid-19 vaccine doses that have been delivered across the U.S. of which around 15.5 million have been administered, according to
. In comparison, Pfizer has delivered over 284.6 million doses while Moderna has delivered 198.5 million doses.The report of unused vaccine doses sitting at a plant comes at a time when the World Health Organization and the United Nations haveabout vaccine inequity around the world. The global health body noted that of the 6.5 billion doses rolled out globally, as of the end of September, nearly 75% was administered by high and upper-middle-income countries.